These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9139487)

  • 21. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.
    Konishi E; Fujii A; Mason PW
    J Virol; 2001 Mar; 75(5):2204-12. PubMed ID: 11160724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice.
    Kulkarni R; Sapkal G; Gore M
    Virus Res; 2012 Dec; 170(1-2):118-25. PubMed ID: 23007095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing effect of vaxfectin on the ability of a Japanese encephalitis DNA vaccine to induce neutralizing antibody in mice.
    Nukuzuma C; Ajiro N; Wheeler CJ; Konishi E
    Viral Immunol; 2003; 16(2):183-9. PubMed ID: 12828869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice.
    Dewasthaly SS; Bhonde GS; Shankarraman V; Biswas SM; Ayachit VM; Gore MM
    Protein Pept Lett; 2007; 14(6):543-51. PubMed ID: 17627594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein.
    Jan LR; Yang CS; Henchal LS; Sumiyoshi H; Summers PL; Dubois DR; Lai CJ
    Am J Trop Med Hyg; 1993 Mar; 48(3):412-23. PubMed ID: 8385887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies.
    Ashok MS; Rangarajan PN
    Vaccine; 1999 Aug; 18(1-2):68-75. PubMed ID: 10501236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
    Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
    Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies.
    Rauthan M; Kaur R; Appaiahgari MB; Vrati S
    Microbes Infect; 2004 Nov; 6(14):1305-11. PubMed ID: 15555537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.
    Konishi E; Pincus S; Paoletti E; Laegreid WW; Shope RE; Mason PW
    Virology; 1992 Sep; 190(1):454-8. PubMed ID: 1326813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
    Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
    J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice.
    Konishi E; Terazawa A; Imoto J
    Vaccine; 2003 May; 21(17-18):1826-32. PubMed ID: 12706666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
    Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
    Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.
    Gao N; Chen W; Zheng Q; Fan DY; Zhang JL; Chen H; Gao GF; Zhou DS; An J
    Immunol Lett; 2010 Mar; 129(1):23-31. PubMed ID: 20064558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
    Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 1999 Mar; 60(3):329-37. PubMed ID: 10466957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.